Enzon Pharmaceuticals Director Unloads $96,193 in Stock (ENZN)
Enzon Pharmaceuticals (NASDAQ:ENZN) Director Robert Lebuhn sold 55,926 shares of the stock on the open market in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $1.72, for a total value of $96,192.72. Following the sale, the director now directly owns 42,189 shares of the company’s stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Enzon Pharmaceuticals (NASDAQ:ENZN) traded up 2.38% on Thursday, hitting $1.72. 162,273 shares of the company’s stock traded hands. Enzon Pharmaceuticals has a 1-year low of $1.54 and a 1-year high of $7.47. The stock has a 50-day moving average of $1.81 and a 200-day moving average of $2.65. The company has a market cap of $75.5 million and a price-to-earnings ratio of 12.17.
Enzon Pharmaceuticals, Inc (NASDAQ:ENZN) is a biotechnology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.